This is to inform you that the Board of Directors of the Company at its Meeting held today i.e. 14th November, 2025 has inter alia, considered and approved the Un-audited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved standalone unaudited financial results for Q2 FY26 (quarter ended Sep 30, 2025) along with the Limited Review Report from auditor C.K. Chandak & Co, which was unqualified. For Q2 FY26, revenue from operations stood at Rs. 34.30 lakhs versus Rs. 89.76 lakhs in Q2 FY25 (a sharp decline of about 62% YoY), while the company posted a loss after tax of Rs. 45.39 lakhs (vs loss of Rs. 66.72 lakhs in Q2 FY25). On a half-year basis (H1 FY26), revenue grew roughly 21% to Rs. 243.66 lakhs from Rs. 201.28 lakhs in H1 FY25, but the period loss remained at Rs. 62.27 lakhs. Operating cash flow was deeply negative at Rs. (264.43) lakhs for H1 FY26, partly offset by Rs. 237.50 lakhs received from share warrant money. The company also allotted 19 lakh convertible warrants on a preferential basis in September 2025, raising Rs. 9.50 crores earmarked for working capital and business expansion.
The stock remains a loss-making small-cap with weak operational performance and negative operating cash flows, though the preferential warrant issue provides fresh funding for working capital. Shareholders should view the widening H1 cash burn and persistent quarterly losses as negatives, while the equity infusion and year-on-year H1 revenue growth offer limited near-term support.